Denovo Biopharma is a private San Diego-based biotech company, also operating in China, providing a novel biomarker solution to personalize drug development. The core technology of the company is its industry's first platform and algorithm to perform de novo genomic biomarker discovery retrospectively using archived clinical samples.

Biotechnology

Denovo Biopharma

Wen Luo

Sudhir Borgonha, MD

Sina Burrell

Matthew Spear, M.D.

Martin Mumenthaler

Holly Huang, PhD, MPH

Anupam Agarwal, MD, MPH

Xiao-Xiong Lu

Tao Shi

Crystal Chen

Larry D. Alphs

Xiangming Fang

Matthew A. Spear

Michael Haller

Carrie Chen

The Clinical Operations and Development team at Denovo Biopharma is responsible for overseeing the planning, execution, and management of clinical trials aimed at advancing personalized drug development. This team collaborates closely with clinical and safety experts to ensure the integrity and efficacy of clinical data, while also driving the development of innovative treatments in oncology and CNS fields. They play a crucial role in integrating novel biomarker solutions into clinical research, enhancing patient outcomes and streamlining drug development processes.

Clinical Operations and Development

Leadership Team

Clinical Operations and Development

About

Team members

Other teams at Denovo Biopharma

Leadership Team